Your browser doesn't support javascript.
loading
Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN.
Guo, Dongsheng; Liu, Haikun; Gao, Ge; Liu, Yanli; Zhuang, Yuanqi; Yang, Fan; Wang, Kepin; Zhou, Tiancheng; Qin, Dajiang; Hong, Liangqing; Li, Jialiang; Xu, Kecheng; Li, Yin-Xiong.
Afiliação
  • Guo D; Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Liu H; Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Gao G; Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Liu Y; Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Zhuang Y; Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Yang F; Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; Guangdong P
  • Wang K; South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Zhou T; South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Qin D; South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Hong L; The third affiliated hospital of Sun Yat-sen University, Department of Kidney Transplantation, Guangzhou, China.
  • Li J; Guangzhou Fuda Cancer Hospital, Guangzhou City, Guangdong Province, China.
  • Xu K; Guangzhou Fuda Cancer Hospital, Guangzhou City, Guangdong Province, China.
  • Li YX; Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; Guangdong P
Stem Cell Res ; 18: 67-69, 2017 01.
Article em En | MEDLINE | ID: mdl-28395809

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligodesoxirribonucleotídeos / Proteínas Proto-Oncogênicas / Células-Tronco Pluripotentes Induzidas / Sistemas CRISPR-Cas Limite: Humans / Male Idioma: En Revista: Stem Cell Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligodesoxirribonucleotídeos / Proteínas Proto-Oncogênicas / Células-Tronco Pluripotentes Induzidas / Sistemas CRISPR-Cas Limite: Humans / Male Idioma: En Revista: Stem Cell Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China